Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.
Objective: The aim of this study is to describe the variability of presentations, etiology, management, follow up and outcome of autoimmune encephalitis, a potentially reversible…Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.
Objective: To study the clinical and neuroimaging features of a patient with a long-term use (more than 10 years) of desomorphine in the anamnesis. Background:…Movement disorders in Brain Sagging Syndrome- A Systematic Review
Objective: Objective: This study aims to systematically review the array of movement disorders observed in patients diagnosed with brain sagging syndrome (BSS) secondary to spontaneous…Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?
Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy
Objective: Introduction: Leukodystrophies are primarily known as childhood diseases, but recent advances in genetic testing and brain imaging have led to an increase in reports…Preventing Medication Errors for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention
Objective: To determine whether a Parkinson’s disease (PD) Inpatient Program will prevent medication errors and ultimately improve the safety and quality of care for hospitalized…Beyond Memory:A Brain Health Awareness Kit for Spanish-speaking Communities
Objective: To develop an interactive workshop in Spanish that provides basic information about brain health and its importance so that community members can identify risk…A Study of Age-related Changes in Galanin Expression in the Neuropil and Associated Boutons in the Human Locus Coeruleus.
Objective: To determine the age-effects on galanin (Gal)-enriched synaptic boutons and neuropil of human locus coeruleus (LC) using autopsied human tissues. Background: The LC has…Addressing Patient Needs: Enhancing Patient-Centered Care at the Movement Disorders Center
Objective: To define patients’ needs and enhance educational and quality improvement initiatives at our center. Background: Patient-centered care is critical for the managing the symptoms…Botulinum Toxin A Usage in Movement Disorder Division: A Retrospective Chart Review
Objective: To evaluate the cost-effectiveness of Botulinum Toxin A in our movement disorder division. Background: Botulinum Toxin A is an FDA-approved treatment for various medical…
- « Previous Page
- 1
- …
- 540
- 541
- 542
- 543
- 544
- …
- 1942
- Next Page »